Vienna General Hospital (AKH)
Glaucoma treatment cost in Austria typically includes essential diagnostics like an ophthalmological investigation, which ranges from $200 to $300. Surgical interventions such as laser trabeculoplasty run from $1,500 to $2,500, while a trabeculotomy costs between $2,500 and $4,500. Total expenses depend on the clinic tier and disease stage. Patients often find significant savings compared to US prices. Vienna and Graz are the primary hubs for care.
Typical Glaucoma Treatment Costs in Austria
Bookimed Expert Insight: Patients seeking world-class surgical expertise should consider Wiener Privatklinik in Vienna. Dr. Rupert Menapace, a top-ranked specialist here, focuses on minimally invasive glaucoma techniques. University-based care at Vienna General Hospital (AKH) serves over 500,000 patients annually with innovative technologies. For those prioritizing accessible diagnostics, Leech Private Clinic in Graz provides modern imaging like OCT and CT. Premium private facilities typically offer all-inclusive surgical packages including overnight stays.
| Turkey | Austria | Spain | |
| Trabeculotomy | from $1,500 | from $2,500 | from $2,500 |
| Laser trabeculoplasty | from $500 | from $1,500 | from $1,200 |
One of Europe's leading ophthalmologists, Prof. Menapace specializes in advanced cataract and intraocular lens surgeries at Wiener Privatklinik.
Leads the Ophthalmology Department at the renowned Vienna General Hospital.
The doctor is a specialist in ophthalmology and optometry, with a focus on cataract and retinal surgery, as well as macular and retinal diseases. Clinical experience includes extensive research work in new therapies for exudative macula diseases, management of therapy refractory exudative macular degeneration, and pathogenesis of retinal vein occlusions. The doctor has been a resident at the Department of Ophthalmology, Medical University of Vienna, since 1999 and has taught ophthalmology to both nursing staff and medical students.
Research projects also cover optimizing local therapy after intravitreal injections, genetic mapping in retinal dystrophies, and establishing genetic therapies for hereditary retinal diseases in collaboration with the University of Pennsylvania. The doctor is a member of the DGII and ESCRS and has received the Theodor-Koerner Science Prize.